Yonhap Infomax NewsOct 23
Citi Group has upgraded BioAge Labs to 'Buy' and doubled its price target, citing strong prospects for its obesity drug pipeline and upcoming data releases.
#YonhapInfomax #BioAgeLabs #CitiGroup #ObesityDrug #BGE102 #PriceTarget #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=86911
Citi Upgrades BioAge Labs to 'Buy' on Obesity Drug Pipeline

Citi Group has upgraded BioAge Labs to 'Buy' and doubled its price target, citing strong prospects for its obesity drug pipeline and upcoming data releases.

Yonhap Infomax